Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric cancer heterogeneity.

X de Aretxabala1, Y Yonemura, K Sugiyama

  • 1Department of Surgery II, School of Medicine, Kanazawa University, Japan.

Cancer
|February 15, 1989
PubMed
Summary

Gastric carcinoma DNA content heterogeneity is common in primary tumors and metastasis. Multiple cell clones in metastasis were observed, with some not present in the primary tumor, indicating complex tumor evolution.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation between altered expression of retinoblastoma protein and clinical outcome in patients with gastric-cancer.

International journal of oncology·2011
Same author

Colonic prostaglandin-e2 in carcinogenesis in rats with N-methyl-n'-nitrosoguanidine.

International journal of oncology·2011
Same author

C-erbb-2, ras p21, and C-myc expression in breast-carcinoma - prognostic value and correlation with clinicopathological and biologic variables.

International journal of oncology·2011
Same author

Nm23 expression versus helix-pomatia lectin-binding in human breast-cancer metastases.

International journal of oncology·2011
Same author

Effects of linoleic acid and eicosanoid synthesis inhibitors on the growth and c-myc oncogene expression of human breast cancer cells.

International journal of oncology·2011
Same author

Correlation between overexpression of c-met gene and the progression of gastric cancer.

International journal of oncology·2011

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gastric carcinoma is a significant global health concern.
  • Understanding tumor heterogeneity is crucial for effective treatment strategies.
  • Genetic instability and the presence of multiple DNA stem lines may drive tumor progression and metastasis.

Purpose of the Study:

  • To investigate the incidence of multiple DNA stem lines in primary gastric tumors and their corresponding lymph node metastases.
  • To assess the relationship between DNA content heterogeneity, epidermal growth factor (EGF) receptor expression, histologic grade, tumor size, and wall infiltration.
  • To identify the presence of distinct metastatic clones not found in the primary tumor.

Main Methods:

  • Flow cytometry was used to analyze DNA content in 222 samples from 37 gastric carcinomas.

Related Experiment Videos

  • Primary tumors and lymph node metastases were analyzed for DNA stem lines and ploidy.
  • Epidermal growth factor (EGF) receptor expression was assessed.
  • Histologic grade, tumor size, and degree of wall infiltration were evaluated.

    • Main Results:

    • Aneuploidy was observed in 59.5% of primary tumors and 70.8% of metastatic lymph nodes.
    • Multiple cell clones (DNA content heterogeneity) were found in 33% of primary tumors and 66.6% of metastases.
    • In 12 patients, metastatic clones were identified that were not present in the primary tumor.
    • DNA content heterogeneity was present even in tumors with submucosal invasion.
    • No correlation was found between DNA distribution and histologic grade.
    • Epidermal growth factor (EGF) receptor expression was constant across samples, irrespective of DNA content or histologic grade.

    Conclusions:

    • Gastric carcinomas frequently exhibit DNA content heterogeneity in both primary tumors and metastases.
    • The emergence of distinct clones in metastasis suggests complex evolutionary pathways.
    • This heterogeneity is present even at early stages of tumor invasion.
    • Epidermal growth factor (EGF) receptor expression appears stable and independent of DNA content heterogeneity or histologic grade in gastric cancer.